Atezolizumab | Tecentriq | Immunotherapy Immune checkpoint inhibitor (anti-PD-L1) |  | https://www.tecentriq.com/ |
Atezolizumab/hyaluronidase-tqjs | Tecentriq Hybreza | Immunotherapy Immune checkpoint inhibitor (anti-PD-L1) |  | https://www.tecentriq.com/hybreza.html |
Binimetinib | Mektovi | Targeted therapy (anti-MEK) Used with encorafenib |  | https://www.braftovi.com/ |
Cobimetinib | Cotellic | Targeted therapy (anti-MEK) Used with vemurafenib
|  | https://www.gene.com/patients/medicines/cotellic |
Dabrafenib | Tafinlar | Targeted therapy (anti-BRAF) Used with trametinib |  | https://us.tafinlarmekinist.com/advanced-melanoma |
Dacarbazine | DTIC-Dome | Chemotherapy |  | https://medlineplus.gov/druginfo/meds/a682750.html |
Encorafenib | Braftovi | Targeted therapy (anti-BRAF) Used with binimetinib |  | https://www.braftovi.com/https://www.braftovi.com/ |
Interleukin-2 (IL-2, aldesleukin) | Proleukin | Immunotherapy |  | https://www.proleukin.com/ |
Ipilimumab | Yervoy | Immunotherapy Immune checkpoint inhibitor (anti-CTLA-4) |  | https://packageinserts.bms.com/medguide/medguide_yervoy.pdf? |
Lifileucel | Amtagvi | Immunotherapy T-cell therapy
|  | https://www.amtagvi.com/ |
Nivolumab | Opdivo | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) |  | https://www.opdivo.com/ |
Nivolumab + hyaluronidase-nhvy | Opdivo Qvantig | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) |  | https://www.opdivohcp.com/efficacy/subcutaneous-administration |
Pembrolizumab | Keytruda | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) |  | https://www.keytruda.com/ |
Relatlimab + nivolumab | Opdualag | Immunotherapy Immune checkpoint inhibitor (anti-LAG-3 + anti-PD-1) |  | https://www.opdualag.com/ |
Talimogene Laherparapvec (T-VEC) | Imlygic | Viral therapy |  | https://www.imlygic.com/ |
Trametinib | Mekinist | Targeted therapy (anti-MEK) Used with dabrafenib) |  | https://us.tafinlarmekinist.com/ |
Vemurafenib | Zelboraf | Targeted therapy (anti-BRAF) |  | https://www.gene.com/patients/medicines/zelboraf |